The Latest Breaking News from GoodRx Holdings

GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?

GoodRx Holdings Inc (NASDAQ:GDRX) shares are pulling back Tuesday morning, as investors potentially take profits following Monday’s surge. The stock had jumped over 30% Monday after the company announced a new partnership with Novo Nordisk to expand access to popular GLP-1 medications.

Benzinga · Aug 19, 2025

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022

Upgrades

Benzinga · Nov 4, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022

 

Benzinga · Sep 16, 2022

Expert Ratings for GoodRx Holdings

Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings:

Benzinga · Jun 1, 2022

Goldman Sachs Maintains Buy Rating for GoodRx Holdings: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $30.00 to $12.00. Shares of GoodRx Holdings are trading up 1.32% over the last 24 hours, at $8.07 per share.

Benzinga · May 11, 2022

What 16 Analyst Ratings Have To Say About GoodRx Holdings

Analysts have provided the following ratings for GoodRx Holdings (NASDAQ:GDRX) within the last quarter:

Benzinga · May 10, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Benzinga · May 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022

Upgrades

Benzinga · May 10, 2022

GoodRx Holdings: Q1 Earnings Insights

GoodRx Holdings (NASDAQ:GDRX) reported its Q1 earnings results on Monday, May 9, 2022 at 04:07 PM. Here's what investors need to know about the announcement. Earnings GoodRx Holdings beat estimated earnings by 25.0%, reporting an EPS of $0.1 versus an estimate of $0.08.

Benzinga · May 9, 2022

Where GoodRx Holdings Stands With Analysts

Over the past 3 months, 13 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Apr 11, 2022